Enkephalinase inhibitor

This page covers all Enkephalinase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Enkephalinase (neutral endopeptidase).

Targets

Enkephalinase (neutral endopeptidase)

Phase 3 pipeline (1)

• Racecadotril plus ORS · Abbott · Gastroenterology
  Racecadotril inhibits enkephalinase to reduce intestinal fluid secretion, while ORS provides oral rehydration therapy to replace lost electrolytes and fluids.

Patent intelligence

• enkephalinase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates